Horizon Pharma rallies again following Cramer comment


Shares of Horizon Pharma (HZNP +9.4%) are moving sharply to the upside in afternoon trading.

The stock may be getting a boost from a positive mention on Jim Cramer's Mad Money Wednesday evening.

Cramer called HZNP "a good spec."

With today's gains, the shares are up some 55% this month, helped tremendously by a well received deal to acquire the rights to Vimovo.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs